Replies to post #3787 on Repros Therapeutics Inc (RPRX)

[quantumdot]

>>an SPA certainly derisks the program from a regulatory standpoint, but perhaps derisking the program clinically - and having that data before having to go to the markets to raise money or to a partner for money - is more important at this juncture? <<

thank, i always appreciate your thoughtful responses. lets hope that the $ last long enough that said clinical derisking occurs in time.